Columbia EM Core ex-China ETF (XCEM) seeks to track an emerging markets index that excludes Chinese companies, providing exposure to developing market equities across countries like India, Taiwan, South Korea, and Brazil. This geographic-focused equity ETF targets investors wanting emerging markets growth potential while avoiding China-specific risks.
How It Works
The fund uses a passively managed, market-capitalization-weighted approach that mirrors its benchmark index composition. Holdings are weighted by market value within the eligible emerging markets universe, automatically excluding all Chinese mainland and Hong Kong-listed companies. Rebalancing occurs quarterly to maintain index alignment and country allocation targets. The strategy provides diversified exposure across multiple emerging economies while maintaining a significant underweight to what is typically the largest emerging market.
Key Features
- Eliminates China exposure entirely, allowing targeted emerging markets investing without the world's second-largest economy's political and regulatory risks
- Provides concentrated access to India, Taiwan, and South Korea which receive higher allocations without China's market cap dominance
- Offers 2.15% dividend yield from emerging market companies typically providing higher income than developed market equivalents
Risks
- This ETF can lose significant value during emerging markets selloffs, potentially declining 40-50% during global risk-off periods like 2008 or 2020
- Currency fluctuations can amplify losses when emerging market currencies weaken against the dollar, adding 10-20% additional volatility to returns
- Political instability, regulatory changes, or economic crises in major holdings like India or Taiwan could cause concentrated losses exceeding broad EM declines
Who Should Own This
Best suited as a satellite holding (5-15% of equity allocation) for experienced investors with high risk tolerance and 7+ year time horizons seeking emerging markets exposure without China. Appropriate for investors who want to tactically avoid Chinese regulatory risks while maintaining developing markets growth potential in diversified portfolios.